vimarsana.com

Drug Treatment Safety News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New Contraindications to Coadministration of Atazanavir

Xylazine Increasingly Found in Canada s Illegal Drug Supply

Europe Approves Neutropenia and Schizophrenia Treatments

US FDA Declines to Approve Merck s Chronic Cough Drug

EMA Committee Recommends Label Update for Some Decongestants

The European Medicines Agency s safety committee on Friday recommended changes to product information for all medicines that contain the ingredient pseudoephedrine to address safety concerns related to neurological and heart-related side effects.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.